These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 6778415
1. [Pharmacokinetics of anti-arrhythmics. 1. Fundamental principles]. Lévy RH. Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1223-8. PubMed ID: 6778415 [No Abstract] [Full Text] [Related]
2. [Pharmacokinetics of anti-arrhythmics. 2. Clinical applications]. Lévy RH, Lévy S, Bricaud H. Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1229-35. PubMed ID: 6778416 [Abstract] [Full Text] [Related]
3. Dosage regimens of antiarrhythmics. 1. Pharmacokinetic properties. Levy RH, Smith GH. Am J Hosp Pharm; 1973 May; 30(5):398-404. PubMed ID: 4704419 [No Abstract] [Full Text] [Related]
4. Disopyramide phosphate: pharmacokinetic and pharmacologic relationships of a new antiarrhythmic agent. Ranney RE, Dean RR, Karim A, Radzialowski FM. Arch Int Pharmacodyn Ther; 1971 May; 191(1):162-88. PubMed ID: 4104224 [No Abstract] [Full Text] [Related]
5. [Clinical pharmacology of propafenone]. Ambrosioni E, Marchesini B. G Ital Cardiol; 1984 Apr; 14(4):285-92. PubMed ID: 6735021 [Abstract] [Full Text] [Related]
6. [Pharmacokinetics of creatinol-o-phosphate]. Marzo A, Ghirardi P, Croce G. Clin Ter; 1972 Sep 15; 62(5):419-30. PubMed ID: 5085247 [No Abstract] [Full Text] [Related]
7. The pharmacokinetics of Norpace. Karim A. Angiology; 1975 Jan 15; 26(1 Pt 2):85-98. PubMed ID: 1090217 [No Abstract] [Full Text] [Related]
8. Clinical pharmacokinetics of some antiarrhythmic drugs. Ochs HR, Greenblatt DJ, Bodem G. Herz; 1979 Aug 15; 4(4):330-43. PubMed ID: 391683 [No Abstract] [Full Text] [Related]
9. [Pharmacokinetics of the new Soviet anti-arrhythmia preparation etacizin]. Gneushev ET, Ponomarenko EL, Kurapov AP, Kukes VG. Farmakol Toksikol; 1984 Aug 15; 47(2):52-4. PubMed ID: 6714405 [Abstract] [Full Text] [Related]
10. [The need of oral depot preparations of the most common anti-arrhythmia agents]. Lunde PK. Tidsskr Nor Laegeforen; 1974 Jan 10; 94(1):44-5. PubMed ID: 4821259 [No Abstract] [Full Text] [Related]
11. [Pharmacokinetics of antiarrhythmia drugs]. Pastelín G, Sánchez VJ, Vásquez R. Arch Inst Cardiol Mex; 1981 Jan 10; 51(1):21-9. PubMed ID: 7212854 [No Abstract] [Full Text] [Related]
12. Pharmacokinetic study of aprindine and moxaprindine in dogs. de Suray JM, Lavis A, Breekpot F. Int J Clin Pharmacol Ther Toxicol; 1981 May 10; 19(5):209-15. PubMed ID: 7251236 [Abstract] [Full Text] [Related]
13. Clinical application of pharmacokinetics for antiarrhythmic drugs. Harrison DC. Arch Mal Coeur Vaiss; 1981 Dec 10; 74 Spec No():65-72. PubMed ID: 6803703 [Abstract] [Full Text] [Related]
14. [The pharmacokinetics of falirytmin given orally to humans]. Weiss M, Sziegoleit W, Henschke E, von Keyserlingk G, Hafemeister G, Pönicke K, Förster W. Pharmazie; 1980 Feb 10; 35(2):123. PubMed ID: 7384184 [No Abstract] [Full Text] [Related]
15. The fate of SU-13197, a new antiarrhythmic drug, in rat and man. Shand DG, Cavanaugh JH, Oates JA. Clin Pharmacol Ther; 1971 Feb 10; 12(5):769-78. PubMed ID: 5568258 [No Abstract] [Full Text] [Related]
16. [The pharmacokinetics and metabolism of bonnecor in rats]. Klemm V, Morgenroth U, Starke F, Zeriatke W, Ioram U. Farmakol Toksikol; 1990 Feb 10; 53(3):43-4. PubMed ID: 2387379 [Abstract] [Full Text] [Related]